GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSRNOG00000012172 | Spi-1 proto-oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | rn6_v1_chr3_+_79918969_79918969 | 0.81 | 9.8e-77 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_55173692 | 158.39 |
ENSRNOT00000064785
ENSRNOT00000029878 ENSRNOT00000029865 ENSRNOT00000060292 ENSRNOT00000000814 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr1_-_198662610 | 121.84 |
ENSRNOT00000055012
|
Sept1
|
septin 1 |
chr13_+_47602692 | 110.09 |
ENSRNOT00000038822
|
Fcmr
|
Fc fragment of IgM receptor |
chr7_+_119482272 | 95.59 |
ENSRNOT00000009544
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr1_-_198577226 | 90.23 |
ENSRNOT00000055013
|
Spn
|
sialophorin |
chr10_-_70802782 | 88.45 |
ENSRNOT00000045867
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr15_+_57221292 | 86.39 |
ENSRNOT00000014502
|
Lcp1
|
lymphocyte cytosolic protein 1 |
chr4_-_170932618 | 84.93 |
ENSRNOT00000007779
|
Arhgdib
|
Rho GDP dissociation inhibitor beta |
chr1_+_198744050 | 82.62 |
ENSRNOT00000024404
|
Itgal
|
integrin subunit alpha L |
chr1_-_226791773 | 77.74 |
ENSRNOT00000082482
ENSRNOT00000065376 ENSRNOT00000054812 ENSRNOT00000086669 |
LOC100911215
|
T-cell surface glycoprotein CD5-like |
chr7_-_119797098 | 76.77 |
ENSRNOT00000009994
|
Rac2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr13_+_89774764 | 74.39 |
ENSRNOT00000005619
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr2_+_93792601 | 71.82 |
ENSRNOT00000014701
ENSRNOT00000077311 |
Fabp4
|
fatty acid binding protein 4 |
chr1_+_219403970 | 65.85 |
ENSRNOT00000029607
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C-associated protein |
chr4_-_157263890 | 65.79 |
ENSRNOT00000065416
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr3_-_63568464 | 64.98 |
ENSRNOT00000068494
|
AABR07052585.2
|
|
chr2_-_190100276 | 64.83 |
ENSRNOT00000015351
|
S100a9
|
S100 calcium binding protein A9 |
chr16_-_19918644 | 63.55 |
ENSRNOT00000083345
ENSRNOT00000023926 |
Plvap
|
plasmalemma vesicle associated protein |
chr1_+_215628785 | 63.37 |
ENSRNOT00000054864
|
Lsp1
|
lymphocyte-specific protein 1 |
chr1_-_227441442 | 63.18 |
ENSRNOT00000028433
|
Ms4a1
|
membrane spanning 4-domains A1 |
chr20_+_4355175 | 60.75 |
ENSRNOT00000000510
|
Gpsm3
|
G-protein signaling modulator 3 |
chr1_-_199439210 | 60.33 |
ENSRNOT00000026699
|
Pycard
|
PYD and CARD domain containing |
chr10_+_83655460 | 60.13 |
ENSRNOT00000008011
|
Gngt2
|
G protein subunit gamma transducin 2 |
chr4_-_44136815 | 60.01 |
ENSRNOT00000086810
|
Tfec
|
transcription factor EC |
chr7_-_107392972 | 59.74 |
ENSRNOT00000093425
|
Tmem71
|
transmembrane protein 71 |
chr1_-_226887156 | 59.48 |
ENSRNOT00000054809
ENSRNOT00000028347 |
Cd6
|
Cd6 molecule |
chr3_-_118959850 | 59.40 |
ENSRNOT00000092750
|
Atp8b4
|
ATPase phospholipid transporting 8B4 (putative) |
chr7_+_142776252 | 59.38 |
ENSRNOT00000008673
|
Acvrl1
|
activin A receptor like type 1 |
chr7_+_142776580 | 59.11 |
ENSRNOT00000081047
|
Acvrl1
|
activin A receptor like type 1 |
chr8_+_96551245 | 58.96 |
ENSRNOT00000039850
|
Bcl2a1
|
BCL2-related protein A1 |
chr1_+_201620642 | 58.94 |
ENSRNOT00000093674
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr20_+_30915213 | 56.50 |
ENSRNOT00000000681
|
Prf1
|
perforin 1 |
chr7_+_18440742 | 56.32 |
ENSRNOT00000011513
|
Myo1f
|
myosin IF |
chr13_-_50916982 | 55.65 |
ENSRNOT00000004408
|
Btg2
|
BTG anti-proliferation factor 2 |
chr3_-_110517163 | 54.46 |
ENSRNOT00000078037
|
Plcb2
|
phospholipase C, beta 2 |
chr13_+_51958834 | 53.28 |
ENSRNOT00000007833
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr10_+_106785077 | 52.81 |
ENSRNOT00000075047
|
Tmc8
|
transmembrane channel-like 8 |
chr5_+_154522119 | 52.49 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr1_-_222118459 | 52.17 |
ENSRNOT00000067217
|
Ccdc88b
|
coiled-coil domain containing 88B |
chr9_+_94745217 | 51.45 |
ENSRNOT00000051338
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr5_+_154265097 | 51.42 |
ENSRNOT00000012342
|
Cnr2
|
cannabinoid receptor 2 |
chr4_+_158088505 | 50.94 |
ENSRNOT00000026643
|
Vwf
|
von Willebrand factor |
chr8_+_133029625 | 50.75 |
ENSRNOT00000008809
|
Ccr3
|
C-C motif chemokine receptor 3 |
chr7_-_107385528 | 50.70 |
ENSRNOT00000093352
|
Tmem71
|
transmembrane protein 71 |
chrX_+_134979646 | 49.54 |
ENSRNOT00000006035
|
Sash3
|
SAM and SH3 domain containing 3 |
chr12_-_20486276 | 49.47 |
ENSRNOT00000074057
|
LOC680910
|
similar to paired immunoglobin-like type 2 receptor beta |
chr4_-_10329241 | 49.33 |
ENSRNOT00000017232
|
Fgl2
|
fibrinogen-like 2 |
chr2_+_183674522 | 49.13 |
ENSRNOT00000014433
|
Tmem154
|
transmembrane protein 154 |
chr7_+_119820537 | 48.96 |
ENSRNOT00000077256
ENSRNOT00000056221 |
Cyth4
|
cytohesin 4 |
chr1_+_81763614 | 48.46 |
ENSRNOT00000027254
|
Cd79a
|
CD79a molecule |
chr1_-_219438779 | 48.31 |
ENSRNOT00000029237
|
Tbc1d10c
|
TBC1 domain family, member 10C |
chr14_-_86146744 | 48.22 |
ENSRNOT00000019335
|
Myl7
|
myosin light chain 7 |
chr2_-_243224883 | 48.18 |
ENSRNOT00000014139
|
Dapp1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
chr7_-_60341264 | 48.13 |
ENSRNOT00000007747
|
Lyz2
|
lysozyme 2 |
chr3_+_28627084 | 47.84 |
ENSRNOT00000049884
|
Arhgap15
|
Rho GTPase activating protein 15 |
chr4_+_90990088 | 47.81 |
ENSRNOT00000030320
|
Mmrn1
|
multimerin 1 |
chr1_+_88875375 | 46.74 |
ENSRNOT00000028284
|
Tyrobp
|
Tyro protein tyrosine kinase binding protein |
chr3_-_6626284 | 46.74 |
ENSRNOT00000012494
|
Fcnb
|
ficolin B |
chr15_-_29443454 | 46.10 |
ENSRNOT00000082167
|
AABR07017635.2
|
|
chr7_+_145068286 | 45.98 |
ENSRNOT00000088956
ENSRNOT00000065753 |
Nckap1l
|
NCK associated protein 1 like |
chr3_+_171037957 | 45.54 |
ENSRNOT00000008764
|
Rbm38
|
RNA binding motif protein 38 |
chr7_-_29233392 | 45.34 |
ENSRNOT00000064241
|
Spic
|
Spi-C transcription factor |
chr15_-_54906203 | 45.11 |
ENSRNOT00000020186
|
Cysltr2
|
cysteinyl leukotriene receptor 2 |
chr2_+_88217188 | 45.10 |
ENSRNOT00000014267
|
Car1
|
carbonic anhydrase I |
chr8_-_133002201 | 44.81 |
ENSRNOT00000008772
|
Ccr1
|
C-C motif chemokine receptor 1 |
chr14_+_91783514 | 44.79 |
ENSRNOT00000080753
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr19_-_19727081 | 44.32 |
ENSRNOT00000020700
|
Adcy7
|
adenylate cyclase 7 |
chr5_-_151459037 | 44.31 |
ENSRNOT00000064472
ENSRNOT00000087836 |
Sytl1
|
synaptotagmin-like 1 |
chr14_-_23604834 | 44.23 |
ENSRNOT00000002760
|
Stap1
|
signal transducing adaptor family member 1 |
chr13_+_83996080 | 44.22 |
ENSRNOT00000004403
ENSRNOT00000070958 |
Cd247
|
Cd247 molecule |
chr4_+_78320190 | 44.03 |
ENSRNOT00000032742
ENSRNOT00000091359 |
Gimap4
|
GTPase, IMAP family member 4 |
chrX_+_78196300 | 43.82 |
ENSRNOT00000048695
|
P2ry10
|
purinergic receptor P2Y10 |
chr10_+_18996523 | 43.52 |
ENSRNOT00000046135
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr6_+_24163026 | 43.37 |
ENSRNOT00000061284
|
Lbh
|
limb bud and heart development |
chr8_-_23148396 | 43.36 |
ENSRNOT00000075237
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr14_-_18849258 | 43.27 |
ENSRNOT00000033406
|
Pf4
|
platelet factor 4 |
chr15_-_34603819 | 43.06 |
ENSRNOT00000067539
|
Cma1
|
chymase 1 |
chr2_+_143656793 | 42.91 |
ENSRNOT00000084527
ENSRNOT00000017453 |
Postn
|
periostin |
chr1_-_221015929 | 42.87 |
ENSRNOT00000028137
|
Sipa1
|
signal-induced proliferation-associated 1 |
chr2_+_189997129 | 42.69 |
ENSRNOT00000015958
|
S100a4
|
S100 calcium-binding protein A4 |
chr14_+_80195715 | 42.65 |
ENSRNOT00000010784
|
Sh3tc1
|
SH3 domain and tetratricopeptide repeats 1 |
chr17_+_28504623 | 42.56 |
ENSRNOT00000021568
|
F13a1
|
coagulation factor XIII A1 chain |
chr19_+_38039564 | 42.47 |
ENSRNOT00000087491
|
Nfatc3
|
nuclear factor of activated T-cells 3 |
chr10_-_83655182 | 42.18 |
ENSRNOT00000007897
|
Abi3
|
ABI family, member 3 |
chr17_+_9639330 | 42.01 |
ENSRNOT00000018232
|
Dok3
|
docking protein 3 |
chr1_+_199555722 | 41.77 |
ENSRNOT00000054983
|
Itgax
|
integrin subunit alpha X |
chr9_-_14668297 | 41.68 |
ENSRNOT00000042404
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr10_+_47930633 | 41.67 |
ENSRNOT00000003515
|
Grap
|
GRB2-related adaptor protein |
chr4_-_113866674 | 41.35 |
ENSRNOT00000010020
|
Dok1
|
docking protein 1 |
chr16_-_9430743 | 41.26 |
ENSRNOT00000043811
|
Wdfy4
|
WDFY family member 4 |
chrX_+_65566047 | 41.24 |
ENSRNOT00000092103
|
Heph
|
hephaestin |
chr4_+_78371121 | 41.17 |
ENSRNOT00000059157
|
Gimap1
|
GTPase, IMAP family member 1 |
chr3_+_119776925 | 40.85 |
ENSRNOT00000018549
|
Dusp2
|
dual specificity phosphatase 2 |
chr7_+_12782491 | 40.38 |
ENSRNOT00000065093
|
Cnn2
|
calponin 2 |
chr1_+_64074231 | 40.03 |
ENSRNOT00000077327
|
Lilrb3l
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3-like |
chr9_-_52238564 | 40.02 |
ENSRNOT00000005073
|
Col5a2
|
collagen type V alpha 2 chain |
chr1_-_101236065 | 39.61 |
ENSRNOT00000066834
|
Cd37
|
CD37 molecule |
chr8_-_49301125 | 39.37 |
ENSRNOT00000091190
|
Cd3e
|
CD3e molecule |
chr5_+_82587420 | 39.23 |
ENSRNOT00000014020
|
Tlr4
|
toll-like receptor 4 |
chr12_+_21678580 | 39.16 |
ENSRNOT00000039797
|
LOC100910669
|
paired immunoglobulin-like type 2 receptor alpha-like |
chr7_+_116632506 | 39.16 |
ENSRNOT00000009811
|
Gpihbp1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
chr11_-_66759402 | 39.12 |
ENSRNOT00000003326
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr11_+_64882288 | 39.11 |
ENSRNOT00000077727
|
Pla1a
|
phospholipase A1 member A |
chr3_+_16610086 | 38.95 |
ENSRNOT00000046231
|
LOC100361009
|
rCG64257-like |
chr1_-_98521706 | 38.86 |
ENSRNOT00000015941
|
Siglec10
|
sialic acid binding Ig-like lectin 10 |
chr6_-_138508753 | 38.47 |
ENSRNOT00000006888
|
Ighm
|
immunoglobulin heavy constant mu |
chr1_+_198528635 | 38.15 |
ENSRNOT00000022765
|
LOC308990
|
hypothetical protein LOC308990 |
chr10_-_87067456 | 38.07 |
ENSRNOT00000014163
|
Ccr7
|
C-C motif chemokine receptor 7 |
chr10_-_103590607 | 38.06 |
ENSRNOT00000034741
|
Cd300le
|
Cd300 molecule-like family member E |
chrX_-_71169038 | 38.03 |
ENSRNOT00000005343
|
Il2rg
|
interleukin 2 receptor subunit gamma |
chr17_-_70548071 | 37.82 |
ENSRNOT00000073144
|
Il2ra
|
interleukin 2 receptor subunit alpha |
chr10_+_91254058 | 37.60 |
ENSRNOT00000087218
ENSRNOT00000065373 |
Fmnl1
|
formin-like 1 |
chr12_-_11265865 | 37.52 |
ENSRNOT00000001315
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B |
chr1_-_260254600 | 37.36 |
ENSRNOT00000019014
|
Blnk
|
B-cell linker |
chr5_+_149056078 | 37.14 |
ENSRNOT00000083028
|
Laptm5
|
lysosomal protein transmembrane 5 |
chr3_-_159775643 | 37.09 |
ENSRNOT00000010939
|
Jph2
|
junctophilin 2 |
chr4_-_95970666 | 36.93 |
ENSRNOT00000008826
|
Hpgds
|
hematopoietic prostaglandin D synthase |
chr7_+_125288081 | 36.91 |
ENSRNOT00000085216
|
Parvg
|
parvin, gamma |
chr5_-_79222687 | 36.91 |
ENSRNOT00000010516
|
Akna
|
AT-hook transcription factor |
chr7_-_143837780 | 36.87 |
ENSRNOT00000016642
|
Itgb7
|
integrin subunit beta 7 |
chr9_+_91001828 | 36.81 |
ENSRNOT00000080956
|
AABR07068214.1
|
|
chr12_+_19714324 | 36.76 |
ENSRNOT00000072303
|
RGD1559588
|
similar to cell surface receptor FDFACT |
chr19_-_10513349 | 36.73 |
ENSRNOT00000061270
|
Adgrg5
|
adhesion G protein-coupled receptor G5 |
chr15_-_34479741 | 36.69 |
ENSRNOT00000027759
|
Ripk3
|
receptor-interacting serine-threonine kinase 3 |
chr9_-_55256340 | 36.57 |
ENSRNOT00000028907
|
Sdpr
|
serum deprivation response |
chr8_-_49308806 | 36.57 |
ENSRNOT00000047291
|
Cd3e
|
CD3e molecule |
chr10_-_56270640 | 36.28 |
ENSRNOT00000056918
|
Cd68
|
Cd68 molecule |
chr11_+_84745904 | 36.26 |
ENSRNOT00000002617
|
Klhl6
|
kelch-like family member 6 |
chr10_-_104921866 | 35.86 |
ENSRNOT00000077158
|
LOC100909671
|
CMRF35-like molecule-like |
chr8_-_33661049 | 35.68 |
ENSRNOT00000068037
|
Fli1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr7_-_107391184 | 35.48 |
ENSRNOT00000056793
|
Tmem71
|
transmembrane protein 71 |
chr13_-_90839411 | 35.40 |
ENSRNOT00000010594
|
Slamf9
|
SLAM family member 9 |
chr17_-_90149894 | 35.27 |
ENSRNOT00000024272
|
Apbb1ip
|
amyloid beta precursor protein binding family B member 1 interacting protein |
chr5_-_147761983 | 35.27 |
ENSRNOT00000012936
|
Lck
|
LCK proto-oncogene, Src family tyrosine kinase |
chr10_+_49000973 | 35.13 |
ENSRNOT00000057880
|
LOC102553715
|
microfibril-associated glycoprotein 4-like |
chr17_+_43734461 | 35.11 |
ENSRNOT00000072564
|
Hist1h1d
|
histone cluster 1, H1d |
chr1_-_7064870 | 34.90 |
ENSRNOT00000019983
|
Stx11
|
syntaxin 11 |
chr3_+_149624712 | 34.84 |
ENSRNOT00000018581
|
Bpifa1
|
BPI fold containing family A, member 1 |
chrX_+_15155230 | 34.83 |
ENSRNOT00000073289
ENSRNOT00000051439 |
Was
|
Wiskott-Aldrich syndrome |
chr5_+_173640780 | 34.74 |
ENSRNOT00000027476
|
Perm1
|
PPARGC1 and ESRR induced regulator, muscle 1 |
chr10_+_94566928 | 34.65 |
ENSRNOT00000078446
|
Prr29
|
proline rich 29 |
chr15_-_34392066 | 34.38 |
ENSRNOT00000027315
|
Tgm1
|
transglutaminase 1 |
chr13_+_68949665 | 34.33 |
ENSRNOT00000003320
|
Fam129a
|
family with sequence similarity 129, member A |
chr18_+_86299463 | 34.20 |
ENSRNOT00000058152
|
Cd226
|
CD226 molecule |
chr8_+_49282460 | 34.17 |
ENSRNOT00000021488
|
Cd3d
|
CD3d molecule |
chr1_-_88881460 | 34.16 |
ENSRNOT00000028287
|
Hcst
|
hematopoietic cell signal transducer |
chr10_-_70871066 | 33.92 |
ENSRNOT00000015139
|
Ccl3
|
C-C motif chemokine ligand 3 |
chr7_-_142300382 | 33.66 |
ENSRNOT00000048262
|
Bin2
|
bridging integrator 2 |
chr12_-_21362205 | 33.46 |
ENSRNOT00000064787
|
LOC108348155
|
paired immunoglobulin-like type 2 receptor beta-2 |
chr20_+_4363152 | 33.35 |
ENSRNOT00000000508
ENSRNOT00000084841 ENSRNOT00000072848 ENSRNOT00000077561 |
Ager
|
advanced glycosylation end product-specific receptor |
chr4_+_163162211 | 33.32 |
ENSRNOT00000082537
|
Clec1b
|
C-type lectin domain family 1, member B |
chr12_-_21670269 | 33.19 |
ENSRNOT00000074863
|
LOC100910801
|
paired immunoglobulin-like type 2 receptor alpha-like |
chr1_+_63759638 | 32.94 |
ENSRNOT00000080799
ENSRNOT00000087669 |
Lilrb3a
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3A |
chrX_+_65226748 | 32.66 |
ENSRNOT00000076181
|
Msn
|
moesin |
chr13_-_89306219 | 32.57 |
ENSRNOT00000004183
ENSRNOT00000079247 |
Fcrla
|
Fc receptor-like A |
chr2_-_45077219 | 32.55 |
ENSRNOT00000014319
|
Gzmk
|
granzyme K |
chr10_+_47765432 | 32.45 |
ENSRNOT00000078231
|
LOC102553715
|
microfibril-associated glycoprotein 4-like |
chr14_+_3058993 | 32.41 |
ENSRNOT00000002807
|
Gfi1
|
growth factor independent 1 transcriptional repressor |
chr19_-_55510460 | 32.40 |
ENSRNOT00000019820
|
Cbfa2t3
|
CBFA2/RUNX1 translocation partner 3 |
chr6_-_103470427 | 32.30 |
ENSRNOT00000091560
ENSRNOT00000088795 ENSRNOT00000079824 |
Actn1
|
actinin, alpha 1 |
chr1_+_227240383 | 32.30 |
ENSRNOT00000074127
|
Ms4a6e
|
membrane spanning 4-domains A6E |
chr1_-_104157855 | 32.23 |
ENSRNOT00000019311
|
Csrp3
|
cysteine and glycine rich protein 3 |
chr2_-_105047984 | 32.17 |
ENSRNOT00000014970
|
Cpa3
|
carboxypeptidase A3 |
chr1_+_252589785 | 32.15 |
ENSRNOT00000025928
|
Fas
|
Fas cell surface death receptor |
chr12_+_38160464 | 32.10 |
ENSRNOT00000032249
|
Hcar2
|
hydroxycarboxylic acid receptor 2 |
chr1_-_78195328 | 31.98 |
ENSRNOT00000073034
|
C5ar1
|
complement C5a receptor 1 |
chr13_+_90244681 | 31.96 |
ENSRNOT00000078162
|
Cd84
|
CD84 molecule |
chr13_+_51022681 | 31.87 |
ENSRNOT00000078599
|
Chi3l1
|
chitinase 3 like 1 |
chr1_+_81779380 | 31.70 |
ENSRNOT00000065865
ENSRNOT00000080143 ENSRNOT00000089592 ENSRNOT00000080840 |
Arhgef1
|
Rho guanine nucleotide exchange factor 1 |
chrX_+_78259409 | 31.63 |
ENSRNOT00000049779
|
RGD1560455
|
similar to RIKEN cDNA A630033H20 gene |
chr6_+_139158334 | 31.54 |
ENSRNOT00000089227
|
AABR07065673.1
|
|
chr7_-_107616038 | 31.12 |
ENSRNOT00000088752
|
Sla
|
src-like adaptor |
chr13_+_50164563 | 31.03 |
ENSRNOT00000029533
|
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr4_-_162025090 | 30.95 |
ENSRNOT00000085887
ENSRNOT00000009904 |
Klrb1a
|
killer cell lectin-like receptor subfamily B, member 1A |
chrX_-_105385852 | 30.94 |
ENSRNOT00000086863
|
Btk
|
Bruton tyrosine kinase |
chr7_+_70614617 | 30.89 |
ENSRNOT00000035382
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr5_+_149047681 | 30.75 |
ENSRNOT00000015198
|
Laptm5
|
lysosomal protein transmembrane 5 |
chr9_-_16795887 | 30.73 |
ENSRNOT00000071609
|
Cd79al
|
Cd79a molecule-like |
chr15_+_57241968 | 30.72 |
ENSRNOT00000082191
|
Lcp1
|
lymphocyte cytosolic protein 1 |
chr10_+_39109522 | 30.69 |
ENSRNOT00000010968
|
Irf1
|
interferon regulatory factor 1 |
chr1_-_191007503 | 30.55 |
ENSRNOT00000023262
|
Igsf6
|
immunoglobulin superfamily, member 6 |
chr13_+_89975267 | 30.52 |
ENSRNOT00000006266
ENSRNOT00000000053 |
Cd244
|
CD244 molecule |
chr4_-_163049084 | 30.45 |
ENSRNOT00000091644
|
Cd69
|
Cd69 molecule |
chr1_+_81230612 | 30.30 |
ENSRNOT00000026489
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr5_-_59063592 | 30.30 |
ENSRNOT00000022400
|
Tln1
|
talin 1 |
chr10_+_104952237 | 30.29 |
ENSRNOT00000085222
|
RGD1559482
|
similar to immunoglobulin superfamily, member 7 |
chrX_+_1311121 | 30.26 |
ENSRNOT00000038909
|
Cfp
|
complement factor properdin |
chr7_+_58814805 | 30.25 |
ENSRNOT00000005909
|
Tspan8
|
tetraspanin 8 |
chr1_+_197999037 | 30.20 |
ENSRNOT00000091065
|
Apobr
|
apolipoprotein B receptor |
chr8_-_21995806 | 30.13 |
ENSRNOT00000028034
|
S1pr2
|
sphingosine-1-phosphate receptor 2 |
chr9_+_65614142 | 30.10 |
ENSRNOT00000016613
|
Casp8
|
caspase 8 |
chr1_+_81230989 | 30.07 |
ENSRNOT00000077952
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr5_+_153507093 | 30.04 |
ENSRNOT00000086650
ENSRNOT00000083645 |
Runx3
|
runt-related transcription factor 3 |
chr18_+_55463308 | 29.91 |
ENSRNOT00000073388
|
LOC100910979
|
interferon-inducible GTPase 1-like |
chr1_-_167347490 | 29.85 |
ENSRNOT00000076499
|
Rhog
|
ras homolog family member G |
chr3_-_142752325 | 29.64 |
ENSRNOT00000006200
|
Thbd
|
thrombomodulin |
chr3_-_44177689 | 29.63 |
ENSRNOT00000006387
|
Cytip
|
cytohesin 1 interacting protein |
chr3_-_14019204 | 29.63 |
ENSRNOT00000072400
ENSRNOT00000092918 |
Traf1
|
TNF receptor-associated factor 1 |
chr2_+_32820322 | 29.58 |
ENSRNOT00000013768
|
Cd180
|
CD180 molecule |
chr15_-_108376221 | 29.52 |
ENSRNOT00000034560
|
Gpr183
|
G protein-coupled receptor 183 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
52.8 | 158.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
40.6 | 121.8 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
30.9 | 92.7 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
30.7 | 30.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
28.3 | 84.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
24.9 | 99.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
24.1 | 96.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
22.4 | 67.2 | GO:0072714 | response to selenite ion(GO:0072714) |
21.6 | 64.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
21.2 | 105.9 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
20.2 | 60.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
20.0 | 59.9 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
19.6 | 39.1 | GO:0042531 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
19.3 | 57.8 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
18.7 | 74.9 | GO:0071307 | cellular response to vitamin K(GO:0071307) |
17.8 | 53.4 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
17.5 | 70.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
17.4 | 34.9 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
16.5 | 98.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
16.2 | 32.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
15.8 | 63.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
15.6 | 93.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
15.4 | 123.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
15.3 | 46.0 | GO:2001187 | actin polymerization-dependent cell motility(GO:0070358) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
15.0 | 15.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
15.0 | 60.0 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
14.7 | 44.2 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
14.5 | 58.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
14.5 | 58.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
14.4 | 144.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
14.3 | 42.9 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
14.0 | 153.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
13.8 | 151.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
13.1 | 39.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
12.7 | 38.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
12.4 | 49.7 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
12.3 | 172.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
12.1 | 24.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
12.0 | 23.9 | GO:0072683 | T cell extravasation(GO:0072683) |
11.9 | 131.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
11.9 | 59.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
11.9 | 35.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
11.8 | 59.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
11.7 | 11.7 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
11.6 | 23.3 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
11.4 | 11.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
11.2 | 44.9 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
11.0 | 44.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
11.0 | 33.0 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
11.0 | 76.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
10.9 | 21.8 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
10.8 | 10.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
10.7 | 32.2 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
10.7 | 118.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
10.4 | 62.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
10.4 | 31.1 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
10.1 | 91.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
10.0 | 40.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
9.9 | 19.9 | GO:0002339 | B cell selection(GO:0002339) |
9.9 | 49.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
9.8 | 29.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
9.6 | 9.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
9.5 | 28.6 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
9.5 | 18.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
9.2 | 36.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
9.1 | 9.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
9.1 | 127.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
9.1 | 27.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
9.0 | 27.1 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
8.9 | 26.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
8.8 | 35.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
8.8 | 26.4 | GO:0002215 | defense response to nematode(GO:0002215) |
8.7 | 52.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
8.6 | 17.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
8.5 | 25.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
8.5 | 25.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
8.0 | 40.0 | GO:0001757 | somite specification(GO:0001757) |
8.0 | 32.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) |
7.9 | 15.9 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
7.9 | 7.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
7.7 | 69.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
7.6 | 30.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
7.6 | 30.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
7.6 | 15.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
7.5 | 29.9 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
7.4 | 36.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
7.4 | 14.7 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
7.3 | 22.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
7.2 | 43.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
7.2 | 21.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
7.0 | 35.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
7.0 | 21.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
7.0 | 34.8 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
7.0 | 13.9 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
6.9 | 27.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
6.9 | 110.9 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
6.9 | 20.6 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
6.9 | 20.6 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
6.8 | 75.2 | GO:0042119 | neutrophil activation(GO:0042119) |
6.8 | 20.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
6.7 | 20.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
6.7 | 13.5 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
6.7 | 47.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
6.5 | 45.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
6.4 | 147.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
6.3 | 19.0 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
6.3 | 38.0 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
6.3 | 6.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
6.3 | 25.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
6.3 | 18.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
6.3 | 12.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
6.2 | 12.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
6.1 | 79.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
6.1 | 18.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
5.9 | 5.9 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
5.8 | 23.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
5.8 | 86.4 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
5.7 | 17.2 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
5.7 | 11.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
5.7 | 108.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
5.7 | 22.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
5.5 | 11.1 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
5.5 | 22.0 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
5.5 | 5.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
5.4 | 16.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
5.4 | 26.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
5.4 | 58.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
5.3 | 32.1 | GO:0033031 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
5.3 | 63.8 | GO:0001878 | response to yeast(GO:0001878) |
5.3 | 16.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
5.3 | 21.3 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
5.3 | 37.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
5.2 | 15.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
5.1 | 51.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
5.1 | 56.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
5.1 | 25.3 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
5.0 | 10.0 | GO:0070839 | divalent metal ion export(GO:0070839) |
5.0 | 14.9 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
5.0 | 34.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
5.0 | 19.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
4.9 | 14.6 | GO:0044209 | AMP salvage(GO:0044209) |
4.8 | 14.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
4.7 | 14.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
4.7 | 14.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
4.7 | 93.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
4.7 | 18.6 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
4.6 | 13.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
4.6 | 37.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
4.6 | 27.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
4.6 | 9.2 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
4.6 | 22.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
4.5 | 22.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
4.5 | 9.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
4.5 | 22.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
4.5 | 13.5 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
4.5 | 13.4 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
4.5 | 44.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.4 | 13.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
4.4 | 44.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
4.4 | 13.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
4.4 | 30.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
4.4 | 26.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
4.4 | 35.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
4.4 | 30.5 | GO:0033622 | integrin activation(GO:0033622) |
4.4 | 69.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
4.4 | 13.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
4.3 | 8.7 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
4.3 | 12.9 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
4.3 | 12.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.3 | 68.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
4.3 | 34.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
4.3 | 21.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
4.2 | 127.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
4.2 | 12.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
4.2 | 46.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
4.2 | 16.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
4.1 | 37.1 | GO:0070417 | cellular response to cold(GO:0070417) |
4.1 | 41.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
4.1 | 12.2 | GO:1903544 | response to butyrate(GO:1903544) |
4.1 | 40.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
4.0 | 20.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
4.0 | 12.0 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
4.0 | 8.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
3.9 | 7.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
3.9 | 98.0 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
3.9 | 38.9 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
3.9 | 46.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
3.9 | 15.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
3.8 | 19.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
3.8 | 3.8 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
3.8 | 15.2 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
3.8 | 52.6 | GO:0030220 | platelet formation(GO:0030220) |
3.7 | 112.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
3.7 | 7.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
3.7 | 44.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
3.7 | 11.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
3.7 | 29.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
3.6 | 3.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
3.6 | 7.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.6 | 43.6 | GO:0072678 | T cell migration(GO:0072678) |
3.6 | 32.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.6 | 32.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
3.5 | 17.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
3.5 | 14.1 | GO:1900086 | cell differentiation involved in salivary gland development(GO:0060689) regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
3.4 | 20.6 | GO:0003383 | apical constriction(GO:0003383) |
3.4 | 27.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
3.4 | 23.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
3.4 | 6.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.4 | 23.6 | GO:0002517 | T cell tolerance induction(GO:0002517) |
3.4 | 47.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
3.4 | 6.7 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
3.4 | 16.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
3.3 | 9.9 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
3.3 | 13.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
3.3 | 3.3 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
3.3 | 13.0 | GO:0061511 | centriole elongation(GO:0061511) |
3.3 | 29.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
3.2 | 16.2 | GO:1904401 | cellular response to Thyroid stimulating hormone(GO:1904401) |
3.2 | 22.7 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
3.2 | 6.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
3.1 | 6.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
3.1 | 12.6 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
3.1 | 18.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.1 | 12.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
3.1 | 6.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
3.1 | 6.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
3.0 | 9.1 | GO:1903903 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) regulation of establishment of T cell polarity(GO:1903903) |
3.0 | 27.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
3.0 | 18.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
3.0 | 51.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
3.0 | 9.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.0 | 20.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.9 | 20.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
2.9 | 35.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.9 | 5.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.9 | 11.6 | GO:0006272 | leading strand elongation(GO:0006272) |
2.9 | 23.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.9 | 14.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
2.9 | 5.7 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
2.8 | 2.8 | GO:0090135 | actin filament branching(GO:0090135) |
2.8 | 17.0 | GO:0008228 | opsonization(GO:0008228) |
2.8 | 8.5 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
2.8 | 19.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.8 | 8.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
2.8 | 24.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
2.7 | 19.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
2.7 | 8.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
2.7 | 27.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.7 | 13.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
2.7 | 43.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.7 | 8.0 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
2.7 | 10.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
2.7 | 34.7 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
2.7 | 23.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
2.6 | 13.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.6 | 13.2 | GO:0048539 | bone marrow development(GO:0048539) |
2.6 | 7.8 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
2.6 | 20.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
2.6 | 33.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
2.6 | 18.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.6 | 20.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
2.6 | 17.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
2.5 | 22.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
2.5 | 20.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.5 | 30.4 | GO:0006265 | DNA topological change(GO:0006265) |
2.5 | 7.6 | GO:0010070 | zygote asymmetric cell division(GO:0010070) |
2.5 | 12.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.5 | 22.6 | GO:0051014 | actin filament severing(GO:0051014) |
2.5 | 5.0 | GO:0099550 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
2.5 | 5.0 | GO:0080144 | amino acid homeostasis(GO:0080144) |
2.5 | 5.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
2.5 | 27.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
2.5 | 61.3 | GO:0071800 | podosome assembly(GO:0071800) |
2.4 | 12.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
2.4 | 12.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
2.4 | 19.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
2.4 | 28.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
2.4 | 7.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
2.4 | 62.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
2.4 | 9.6 | GO:0045061 | thymic T cell selection(GO:0045061) |
2.4 | 7.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
2.4 | 7.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.4 | 4.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
2.3 | 58.1 | GO:0019835 | cytolysis(GO:0019835) |
2.3 | 6.9 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
2.3 | 6.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.3 | 6.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
2.3 | 6.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
2.3 | 15.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.3 | 22.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.2 | 55.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
2.2 | 15.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 22.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
2.2 | 8.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
2.2 | 4.3 | GO:0090290 | positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
2.1 | 10.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.1 | 10.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
2.1 | 52.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
2.1 | 12.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
2.1 | 10.6 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
2.1 | 16.8 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
2.1 | 4.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.1 | 21.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.1 | 21.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
2.1 | 12.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
2.1 | 29.1 | GO:0015671 | oxygen transport(GO:0015671) |
2.1 | 6.2 | GO:0061009 | common bile duct development(GO:0061009) |
2.0 | 38.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.0 | 14.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.0 | 8.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.0 | 16.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.0 | 30.0 | GO:0030168 | platelet activation(GO:0030168) |
2.0 | 7.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.0 | 3.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.0 | 13.7 | GO:0072347 | response to anesthetic(GO:0072347) |
2.0 | 5.9 | GO:0006116 | NADH oxidation(GO:0006116) |
2.0 | 7.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.9 | 5.8 | GO:0097298 | regulation of nucleus size(GO:0097298) |
1.9 | 3.9 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
1.9 | 3.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.9 | 15.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.9 | 5.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.9 | 7.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.9 | 15.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.9 | 37.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
1.9 | 20.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.9 | 7.5 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.9 | 7.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.8 | 20.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.8 | 5.5 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
1.8 | 20.1 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.8 | 1.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.8 | 5.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.8 | 3.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.8 | 7.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
1.8 | 7.3 | GO:0003360 | brainstem development(GO:0003360) |
1.8 | 21.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
1.8 | 14.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.8 | 19.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.8 | 25.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.8 | 10.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.8 | 23.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.8 | 23.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.8 | 19.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.8 | 8.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.8 | 5.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.8 | 10.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.7 | 6.9 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.7 | 18.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.7 | 13.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.7 | 13.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.7 | 3.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.7 | 5.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) negative regulation of hair follicle development(GO:0051799) |
1.7 | 5.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.6 | 19.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
1.6 | 4.9 | GO:0032258 | CVT pathway(GO:0032258) |
1.6 | 3.3 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
1.6 | 30.8 | GO:0007567 | parturition(GO:0007567) |
1.6 | 27.2 | GO:0019532 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
1.6 | 71.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.6 | 9.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.6 | 4.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
1.6 | 18.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.5 | 9.2 | GO:1903412 | response to bile acid(GO:1903412) |
1.5 | 19.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.5 | 16.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
1.5 | 9.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.5 | 13.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.5 | 27.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
1.5 | 10.5 | GO:0060056 | mammary gland involution(GO:0060056) |
1.5 | 4.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
1.5 | 181.7 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
1.5 | 10.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.5 | 13.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.5 | 171.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
1.5 | 8.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.5 | 4.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.5 | 1.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.4 | 4.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.4 | 9.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.4 | 38.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
1.4 | 32.4 | GO:0014850 | response to muscle activity(GO:0014850) |
1.4 | 56.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.4 | 49.0 | GO:0070527 | platelet aggregation(GO:0070527) |
1.4 | 7.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
1.4 | 5.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.4 | 9.7 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
1.4 | 8.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
1.4 | 5.5 | GO:0002159 | desmosome assembly(GO:0002159) |
1.4 | 13.7 | GO:0014029 | neural crest formation(GO:0014029) |
1.4 | 6.8 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
1.4 | 9.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.3 | 14.8 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.3 | 5.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.3 | 30.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.3 | 11.9 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
1.3 | 5.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.3 | 3.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
1.3 | 23.7 | GO:0097421 | liver regeneration(GO:0097421) |
1.3 | 10.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.3 | 7.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.3 | 5.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.3 | 5.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.3 | 2.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.3 | 5.2 | GO:0051299 | centrosome separation(GO:0051299) |
1.3 | 5.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.3 | 32.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.3 | 3.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.3 | 1.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.3 | 11.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.3 | 5.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.3 | 16.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.3 | 11.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.3 | 8.8 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
1.3 | 8.8 | GO:0043476 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.2 | 1.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.2 | 11.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.2 | 17.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.2 | 12.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.2 | 3.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 9.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.2 | 1.2 | GO:1990646 | cellular response to prolactin(GO:1990646) |
1.2 | 3.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.2 | 9.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.2 | 4.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.2 | 4.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.2 | 366.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.2 | 3.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
1.2 | 4.6 | GO:0002188 | translation reinitiation(GO:0002188) |
1.1 | 61.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.1 | 5.7 | GO:0032202 | telomere assembly(GO:0032202) |
1.1 | 46.4 | GO:0007596 | blood coagulation(GO:0007596) |
1.1 | 5.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 3.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.1 | 46.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.1 | 6.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.1 | 6.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 13.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.1 | 31.6 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
1.1 | 6.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.1 | 24.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
1.1 | 4.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
1.1 | 5.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
1.0 | 4.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.0 | 3.1 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
1.0 | 6.2 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
1.0 | 8.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.0 | 3.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
1.0 | 13.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
1.0 | 4.0 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
1.0 | 33.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
1.0 | 6.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 19.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.0 | 40.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.0 | 27.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 2.9 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.0 | 6.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 2.9 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
1.0 | 5.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 5.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.0 | 3.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 8.5 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.9 | 3.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.9 | 6.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.9 | 4.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.9 | 12.9 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.9 | 5.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.9 | 2.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.9 | 87.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.9 | 5.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.9 | 15.4 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.9 | 7.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.9 | 33.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.9 | 71.9 | GO:0042113 | B cell activation(GO:0042113) |
0.9 | 10.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.9 | 5.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.9 | 1.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 2.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.9 | 13.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.9 | 81.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.9 | 15.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.9 | 40.4 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.9 | 5.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 13.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.8 | 8.4 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.8 | 3.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.8 | 9.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.8 | 9.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.8 | 10.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.8 | 6.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.8 | 4.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.8 | 5.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.8 | 5.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.8 | 19.5 | GO:0071593 | lymphocyte aggregation(GO:0071593) |
0.8 | 3.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 2.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.8 | 6.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.8 | 4.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.8 | 4.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.8 | 1.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.7 | 3.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.7 | 12.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.7 | 2.2 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.7 | 1.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 7.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 6.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 19.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.7 | 2.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.7 | 9.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.7 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.7 | 2.1 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.7 | 1.4 | GO:0071454 | cellular response to anoxia(GO:0071454) cellular response to sodium arsenite(GO:1903936) |
0.7 | 10.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.7 | 14.3 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.7 | 3.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.7 | 6.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 3.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.7 | 4.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.6 | 10.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.6 | 4.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.6 | 2.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 5.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 5.0 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.6 | 6.9 | GO:0036065 | fucosylation(GO:0036065) |
0.6 | 2.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 3.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.6 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.6 | 8.5 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 1.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.6 | 17.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.6 | 2.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 1.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.6 | 2.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.6 | 9.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.6 | 2.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 4.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 3.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.6 | 1.1 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.6 | 6.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.5 | 1.6 | GO:1900108 | sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 4.3 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
0.5 | 3.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 1.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 10.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 6.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.5 | 2.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.5 | 2.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.5 | 13.0 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.5 | 4.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.5 | 6.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 13.9 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.5 | 11.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.5 | 4.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 7.9 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 | 4.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 1.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 6.7 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.5 | 2.4 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.5 | 0.9 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.5 | 9.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 18.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 2.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 5.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 2.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.4 | 3.1 | GO:0060343 | trabecula formation(GO:0060343) bone trabecula formation(GO:0060346) |
0.4 | 4.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 2.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 19.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 21.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.4 | 10.0 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.4 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 7.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.4 | 13.2 | GO:0009409 | response to cold(GO:0009409) |
0.4 | 18.9 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.4 | 1.2 | GO:0090249 | cell motility involved in somitogenic axis elongation(GO:0090247) regulation of cell motility involved in somitogenic axis elongation(GO:0090249) |
0.4 | 2.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 24.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.4 | 21.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.4 | 11.9 | GO:0097502 | mannosylation(GO:0097502) |
0.4 | 1.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 3.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 2.6 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.4 | 2.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 4.6 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.3 | 2.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 3.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 6.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 5.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 3.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 3.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 1.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) |
0.3 | 2.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 8.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.3 | 6.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 4.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 13.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.3 | 23.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 2.8 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.3 | 2.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 6.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 7.4 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.3 | 4.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 7.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 4.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 6.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 3.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 5.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 2.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 2.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 8.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 7.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 3.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.2 | 1.4 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 2.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.2 | 32.9 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.2 | 5.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 2.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 5.2 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 4.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 36.1 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway(GO:0007169) |
0.2 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 2.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 3.7 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 4.8 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.2 | 0.6 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 3.3 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 5.9 | GO:0030217 | T cell differentiation(GO:0030217) |
0.2 | 1.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 5.8 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 3.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 3.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 4.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 5.0 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 3.1 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.1 | 1.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.3 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.8 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.4 | GO:0009838 | abscission(GO:0009838) negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 4.7 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 2.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 1.1 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 1.0 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.4 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.4 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.0 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.5 | 220.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
21.8 | 43.5 | GO:0036398 | TCR signalosome(GO:0036398) |
19.8 | 59.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
18.3 | 36.7 | GO:0097342 | ripoptosome(GO:0097342) |
18.2 | 54.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
15.9 | 79.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
14.0 | 42.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
13.2 | 132.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
12.3 | 184.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
12.1 | 48.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
12.1 | 60.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) AIM2 inflammasome complex(GO:0097169) |
10.5 | 42.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
10.2 | 82.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
10.0 | 40.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
9.5 | 28.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
9.5 | 28.5 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
9.4 | 56.5 | GO:0031904 | endosome lumen(GO:0031904) |
9.3 | 288.0 | GO:0008305 | integrin complex(GO:0008305) |
9.2 | 18.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
8.9 | 53.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
8.5 | 50.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
8.5 | 16.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
8.1 | 32.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
7.5 | 112.5 | GO:0072687 | meiotic spindle(GO:0072687) |
7.3 | 29.2 | GO:0044299 | C-fiber(GO:0044299) |
7.3 | 29.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
6.6 | 72.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
6.6 | 26.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
6.4 | 19.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
6.3 | 18.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
6.2 | 168.3 | GO:0001891 | phagocytic cup(GO:0001891) |
6.0 | 53.8 | GO:0032009 | early phagosome(GO:0032009) |
5.6 | 106.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
5.5 | 38.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
5.4 | 48.6 | GO:0031209 | SCAR complex(GO:0031209) |
5.0 | 15.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
4.7 | 14.1 | GO:0070110 | interleukin-6 receptor complex(GO:0005896) ciliary neurotrophic factor receptor complex(GO:0070110) |
4.3 | 13.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
4.3 | 34.6 | GO:0097443 | sorting endosome(GO:0097443) |
4.3 | 13.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
4.2 | 33.4 | GO:0043219 | lateral loop(GO:0043219) |
4.1 | 12.4 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
3.9 | 27.4 | GO:0030870 | Mre11 complex(GO:0030870) |
3.8 | 110.7 | GO:0001772 | immunological synapse(GO:0001772) |
3.8 | 11.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
3.7 | 54.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
3.6 | 14.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
3.5 | 60.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
3.5 | 63.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
3.5 | 945.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
3.5 | 14.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
3.3 | 79.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
3.3 | 13.2 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.2 | 12.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.1 | 55.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
3.0 | 158.1 | GO:0031672 | A band(GO:0031672) |
3.0 | 72.3 | GO:0005605 | basal lamina(GO:0005605) |
2.9 | 8.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
2.9 | 20.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.8 | 8.5 | GO:0044609 | DBIRD complex(GO:0044609) |
2.8 | 13.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.8 | 8.4 | GO:0043511 | inhibin complex(GO:0043511) |
2.8 | 5.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.7 | 19.1 | GO:0090543 | Flemming body(GO:0090543) |
2.7 | 13.6 | GO:0071797 | LUBAC complex(GO:0071797) |
2.7 | 10.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
2.6 | 33.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.6 | 23.4 | GO:0097433 | dense body(GO:0097433) |
2.5 | 12.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.5 | 50.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.5 | 22.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
2.4 | 78.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
2.4 | 270.5 | GO:0005884 | actin filament(GO:0005884) |
2.4 | 7.2 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
2.3 | 15.9 | GO:0031527 | filopodium membrane(GO:0031527) |
2.3 | 38.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.2 | 24.6 | GO:0042555 | MCM complex(GO:0042555) |
2.2 | 8.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 15.2 | GO:0097452 | GAIT complex(GO:0097452) |
2.1 | 197.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
2.1 | 14.9 | GO:0031415 | NatA complex(GO:0031415) |
2.1 | 23.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.1 | 10.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.1 | 23.0 | GO:0097542 | ciliary tip(GO:0097542) |
2.1 | 150.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
2.1 | 78.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.1 | 35.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
2.0 | 175.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
2.0 | 16.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.9 | 7.8 | GO:0032059 | bleb(GO:0032059) |
1.9 | 32.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.9 | 7.7 | GO:0072487 | MSL complex(GO:0072487) |
1.9 | 7.5 | GO:0033503 | HULC complex(GO:0033503) |
1.8 | 22.0 | GO:0008278 | cohesin complex(GO:0008278) |
1.8 | 7.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.8 | 17.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.8 | 5.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.7 | 6.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.7 | 37.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.7 | 8.3 | GO:0034455 | t-UTP complex(GO:0034455) |
1.7 | 5.0 | GO:0097444 | spine apparatus(GO:0097444) |
1.7 | 19.8 | GO:0005687 | U4 snRNP(GO:0005687) |
1.6 | 42.4 | GO:0002102 | podosome(GO:0002102) |
1.6 | 16.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.6 | 14.5 | GO:0032982 | myosin filament(GO:0032982) |
1.6 | 11.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.6 | 6.3 | GO:1990005 | granular vesicle(GO:1990005) |
1.6 | 14.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 9.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.5 | 12.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.5 | 15.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.5 | 18.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.4 | 70.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.4 | 10.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 28.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.4 | 2.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.4 | 22.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 42.1 | GO:0046930 | pore complex(GO:0046930) |
1.4 | 15.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.4 | 16.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.4 | 13.6 | GO:0042588 | zymogen granule(GO:0042588) |
1.3 | 17.5 | GO:0031932 | TORC2 complex(GO:0031932) |
1.3 | 8.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 8.0 | GO:0045180 | basal cortex(GO:0045180) |
1.3 | 13.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.3 | 24.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 11.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.3 | 33.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.3 | 3.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.2 | 6.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.2 | 8.6 | GO:0000796 | condensin complex(GO:0000796) |
1.2 | 3.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.2 | 5.9 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) RNA polymerase II transcription repressor complex(GO:0090571) |
1.2 | 105.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.1 | 84.8 | GO:0005604 | basement membrane(GO:0005604) |
1.1 | 5.7 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 4.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.1 | 126.9 | GO:0030027 | lamellipodium(GO:0030027) |
1.1 | 152.6 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 11.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.1 | 47.8 | GO:0032587 | ruffle membrane(GO:0032587) |
1.1 | 5.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 6.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.1 | 57.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.1 | 104.2 | GO:0016605 | PML body(GO:0016605) |
1.1 | 5.4 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 10.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.1 | 22.1 | GO:0005771 | multivesicular body(GO:0005771) |
1.0 | 28.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 4.2 | GO:0070938 | contractile ring(GO:0070938) |
1.0 | 5.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 26.5 | GO:0016459 | myosin complex(GO:0016459) |
1.0 | 15.6 | GO:0019013 | viral nucleocapsid(GO:0019013) |
1.0 | 36.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
1.0 | 3.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 6.7 | GO:0030057 | desmosome(GO:0030057) |
1.0 | 7.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 226.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.9 | 7.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.9 | 20.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.9 | 66.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 5.5 | GO:0016589 | NURF complex(GO:0016589) |
0.9 | 11.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.9 | 22.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.9 | 15.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.9 | 3.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.9 | 18.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 6.7 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 3.1 | GO:0000938 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
0.7 | 42.7 | GO:0005901 | caveola(GO:0005901) |
0.7 | 4.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.7 | 3.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 2.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 3.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 6.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 1.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 46.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 10.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.6 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 8.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 46.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.6 | 8.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 2.8 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 8.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 173.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 5.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 161.2 | GO:0009986 | cell surface(GO:0009986) |
0.5 | 3.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.5 | 1.6 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.5 | 166.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.5 | 23.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 18.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 31.3 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 484.3 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 10.5 | GO:0097546 | ciliary base(GO:0097546) |
0.5 | 3.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 2.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 4.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 3.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.4 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 5.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 2.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 11.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 47.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.4 | 4.4 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 9.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 8.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 18.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 20.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 4.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 6.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 13.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 3.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 8.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 40.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 2.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 1.8 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.8 | GO:0016282 | eukaryotic 43S preinitiation complex(GO:0016282) |
0.2 | 5.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 3.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 3.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 8.2 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 3.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 1.5 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 124.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 3.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.7 | 213.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
23.0 | 46.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
21.6 | 129.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
21.1 | 63.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
19.7 | 98.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
19.2 | 57.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
17.4 | 69.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
16.4 | 98.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
15.5 | 154.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
14.8 | 59.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
14.7 | 44.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
14.6 | 87.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
12.9 | 51.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) PTB domain binding(GO:0051425) |
12.7 | 38.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
12.5 | 62.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
12.3 | 86.3 | GO:0035375 | zymogen binding(GO:0035375) |
11.8 | 47.3 | GO:0035877 | death effector domain binding(GO:0035877) |
11.5 | 287.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
11.0 | 109.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
10.7 | 32.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
10.6 | 74.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
10.6 | 31.7 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
10.4 | 31.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
10.3 | 51.3 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
10.0 | 49.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
9.8 | 39.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
9.7 | 29.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
9.5 | 47.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
9.4 | 47.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
8.8 | 35.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
8.6 | 60.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
8.6 | 60.1 | GO:0003924 | GTPase activity(GO:0003924) |
8.5 | 25.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
8.5 | 51.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
8.5 | 25.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
8.1 | 32.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
8.0 | 32.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
7.6 | 22.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
7.5 | 74.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
7.4 | 22.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
7.4 | 59.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
7.3 | 51.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
7.3 | 94.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
7.2 | 21.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
7.0 | 28.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
6.9 | 27.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
6.9 | 41.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
6.7 | 20.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
6.6 | 99.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
6.6 | 26.3 | GO:0042806 | fucose binding(GO:0042806) |
6.5 | 39.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
6.4 | 45.1 | GO:0004064 | arylesterase activity(GO:0004064) |
6.2 | 24.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
6.0 | 48.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
6.0 | 24.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
5.9 | 35.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
5.9 | 35.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
5.7 | 45.5 | GO:0030274 | LIM domain binding(GO:0030274) |
5.6 | 45.0 | GO:0035197 | siRNA binding(GO:0035197) |
5.5 | 88.3 | GO:0051400 | BH domain binding(GO:0051400) |
5.5 | 22.0 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
5.5 | 142.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
5.3 | 31.9 | GO:0004568 | chitinase activity(GO:0004568) |
5.3 | 37.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
5.3 | 26.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
5.2 | 25.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
5.0 | 20.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
4.9 | 14.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
4.8 | 14.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
4.7 | 28.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
4.7 | 51.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
4.6 | 31.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
4.5 | 22.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
4.4 | 13.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
4.3 | 17.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
4.3 | 17.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
4.2 | 8.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
4.2 | 16.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
4.0 | 28.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
4.0 | 32.0 | GO:0016936 | galactoside binding(GO:0016936) |
4.0 | 75.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
3.9 | 7.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
3.9 | 15.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.9 | 19.4 | GO:0032405 | mismatch base pair DNA N-glycosylase activity(GO:0000700) MutLalpha complex binding(GO:0032405) |
3.9 | 50.5 | GO:0003796 | lysozyme activity(GO:0003796) |
3.8 | 3.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
3.8 | 26.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
3.8 | 45.4 | GO:0015026 | coreceptor activity(GO:0015026) |
3.8 | 22.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
3.7 | 37.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
3.7 | 26.1 | GO:0048495 | Roundabout binding(GO:0048495) |
3.7 | 70.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
3.6 | 10.9 | GO:0008142 | oxysterol binding(GO:0008142) |
3.6 | 21.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.6 | 28.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
3.6 | 10.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
3.6 | 118.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
3.5 | 63.1 | GO:0005522 | profilin binding(GO:0005522) |
3.5 | 24.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
3.5 | 24.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
3.4 | 86.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
3.4 | 64.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
3.4 | 27.1 | GO:0045545 | syndecan binding(GO:0045545) |
3.4 | 40.4 | GO:0004950 | chemokine receptor activity(GO:0004950) |
3.3 | 140.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
3.3 | 9.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
3.2 | 9.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
3.2 | 9.6 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
3.2 | 22.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
3.2 | 79.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
3.2 | 50.5 | GO:0017166 | vinculin binding(GO:0017166) |
3.1 | 18.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
3.1 | 9.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
3.1 | 18.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
3.1 | 96.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
3.1 | 36.8 | GO:0031432 | titin binding(GO:0031432) |
3.1 | 61.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
3.0 | 12.2 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.0 | 66.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
3.0 | 30.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
3.0 | 14.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.9 | 8.8 | GO:0051373 | FATZ binding(GO:0051373) |
2.9 | 23.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.9 | 14.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.8 | 25.5 | GO:0043495 | protein anchor(GO:0043495) |
2.8 | 8.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
2.8 | 14.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.8 | 8.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.8 | 8.4 | GO:0035198 | miRNA binding(GO:0035198) |
2.8 | 19.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.8 | 44.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
2.8 | 11.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.8 | 33.2 | GO:1990405 | protein antigen binding(GO:1990405) |
2.7 | 41.2 | GO:0043274 | phospholipase binding(GO:0043274) |
2.7 | 37.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.6 | 15.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.6 | 15.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
2.6 | 105.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.5 | 12.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.5 | 44.6 | GO:0031996 | thioesterase binding(GO:0031996) |
2.5 | 19.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.4 | 14.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.4 | 74.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.4 | 33.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
2.4 | 19.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.4 | 30.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.3 | 41.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
2.3 | 6.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
2.3 | 11.3 | GO:0005534 | galactose binding(GO:0005534) |
2.3 | 27.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.2 | 33.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
2.2 | 617.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
2.2 | 6.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
2.2 | 8.9 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
2.2 | 8.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
2.2 | 8.7 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
2.1 | 21.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.1 | 6.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
2.1 | 19.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.1 | 4.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.0 | 8.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
2.0 | 138.2 | GO:0019843 | rRNA binding(GO:0019843) |
2.0 | 18.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
2.0 | 15.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.0 | 13.8 | GO:0030957 | Tat protein binding(GO:0030957) |
2.0 | 57.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.9 | 7.8 | GO:0050700 | CARD domain binding(GO:0050700) |
1.9 | 15.2 | GO:0008143 | poly(A) binding(GO:0008143) |
1.9 | 76.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.9 | 35.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.8 | 7.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.8 | 27.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.8 | 10.8 | GO:0031013 | troponin I binding(GO:0031013) |
1.8 | 16.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.8 | 23.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.8 | 45.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.8 | 52.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.7 | 10.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.7 | 12.1 | GO:0003896 | DNA primase activity(GO:0003896) |
1.7 | 13.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKB receptor binding(GO:0005169) |
1.7 | 3.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.7 | 8.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.7 | 25.2 | GO:0001618 | virus receptor activity(GO:0001618) |
1.7 | 1.7 | GO:0048030 | disaccharide binding(GO:0048030) |
1.7 | 8.4 | GO:0034711 | inhibin binding(GO:0034711) |
1.7 | 33.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.6 | 53.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.6 | 8.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.6 | 16.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.6 | 120.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.6 | 56.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.6 | 18.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.6 | 60.7 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
1.5 | 40.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.5 | 4.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.5 | 152.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.5 | 7.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.5 | 127.8 | GO:0005178 | integrin binding(GO:0005178) |
1.5 | 24.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.5 | 16.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 34.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.5 | 32.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.4 | 6.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.4 | 12.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.4 | 6.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.3 | 30.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 7.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.3 | 10.5 | GO:0005113 | patched binding(GO:0005113) |
1.3 | 7.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 13.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.3 | 5.1 | GO:0032190 | acrosin binding(GO:0032190) |
1.3 | 6.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 15.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.2 | 15.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.2 | 51.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.2 | 20.2 | GO:0043236 | laminin binding(GO:0043236) |
1.2 | 5.9 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 5.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 16.5 | GO:0001968 | fibronectin binding(GO:0001968) |
1.2 | 22.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 161.5 | GO:0051015 | actin filament binding(GO:0051015) |
1.2 | 81.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.2 | 3.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.2 | 17.3 | GO:0070888 | E-box binding(GO:0070888) |
1.1 | 6.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 2.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.1 | 2.3 | GO:0019961 | interferon binding(GO:0019961) |
1.1 | 6.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.1 | 3.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 10.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.1 | 5.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.1 | 2.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.1 | 3.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.1 | 6.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 6.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.1 | 14.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.1 | 4.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 6.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.0 | 8.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 2.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.0 | 8.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.0 | 127.3 | GO:0008201 | heparin binding(GO:0008201) |
1.0 | 8.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.0 | 8.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.0 | 7.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 6.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
1.0 | 10.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.0 | 356.7 | GO:0005525 | GTP binding(GO:0005525) |
1.0 | 17.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 4.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 4.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.9 | 119.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.9 | 7.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.9 | 206.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.9 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.9 | 2.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.9 | 20.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.9 | 15.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.9 | 3.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.9 | 6.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.9 | 2.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.9 | 35.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.9 | 226.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.9 | 7.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.9 | 6.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.9 | 21.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 3.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.9 | 34.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.8 | 4.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 6.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 5.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.8 | 10.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.8 | 231.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.8 | 8.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 3.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 7.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.8 | 219.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.7 | 2.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 2.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 31.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.7 | 2.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 33.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.7 | 24.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.7 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.7 | 3.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 21.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.6 | 30.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.6 | 1.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 7.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.6 | 62.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.6 | 16.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.6 | 3.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 3.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.6 | 39.4 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.6 | 7.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.6 | 39.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.6 | 1.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.5 | 1.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 8.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 11.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.5 | 17.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.5 | 21.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 3.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 3.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 12.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 1.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.5 | 16.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 1.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 4.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 5.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 2.2 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.4 | 3.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 8.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 17.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 10.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 1.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.4 | 6.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 5.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 7.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 9.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.4 | 1.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 1.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 106.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.4 | 4.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 7.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 7.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 3.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 4.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 8.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 2.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 10.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 3.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 0.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.3 | 1.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) endothelin receptor activity(GO:0004962) |
0.2 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 2.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 4.0 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 3.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 2.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 15.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 7.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 2.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.4 | GO:0070697 | activin receptor binding(GO:0070697) |
0.2 | 38.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 3.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 8.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 4.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 7.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 6.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 2.9 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 1.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 11.2 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 2.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 2.5 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.6 | 53.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
9.4 | 271.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
9.4 | 618.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
9.3 | 102.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
8.8 | 158.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
8.1 | 484.9 | PID BCR 5PATHWAY | BCR signaling pathway |
7.7 | 161.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
5.8 | 87.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
5.0 | 156.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
4.8 | 28.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
4.6 | 105.1 | PID ENDOTHELIN PATHWAY | Endothelins |
4.5 | 80.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
4.4 | 79.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
4.4 | 48.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
4.2 | 253.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
4.1 | 62.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
4.1 | 126.6 | PID ALK1 PATHWAY | ALK1 signaling events |
4.0 | 210.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
4.0 | 28.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
3.9 | 73.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
3.8 | 142.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
3.7 | 125.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
3.5 | 49.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
3.3 | 66.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
3.2 | 19.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
3.2 | 140.1 | PID AURORA B PATHWAY | Aurora B signaling |
3.0 | 60.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.9 | 26.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
2.9 | 64.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
2.8 | 22.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.7 | 5.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.7 | 66.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
2.6 | 39.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.4 | 191.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.4 | 40.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
2.3 | 63.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.3 | 93.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
2.3 | 57.8 | PID RHOA PATHWAY | RhoA signaling pathway |
2.3 | 52.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.3 | 453.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
2.2 | 94.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
2.2 | 8.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.1 | 18.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.1 | 10.4 | ST GAQ PATHWAY | G alpha q Pathway |
2.0 | 34.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.0 | 14.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.8 | 16.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.8 | 14.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.7 | 43.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.6 | 63.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.6 | 36.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.5 | 182.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.5 | 6.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.5 | 18.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.5 | 33.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.5 | 21.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.5 | 65.4 | PID E2F PATHWAY | E2F transcription factor network |
1.4 | 38.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.3 | 38.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.3 | 19.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.3 | 199.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.3 | 36.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.3 | 6.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.3 | 22.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.2 | 5.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.2 | 50.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.2 | 21.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.1 | 44.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.1 | 24.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.0 | 35.4 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 5.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.0 | 39.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.0 | 7.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.9 | 8.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 27.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 7.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 7.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 9.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 13.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 10.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 5.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 9.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 4.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 9.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 4.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 5.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 15.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 6.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 4.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 4.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 4.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 21.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 13.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 9.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 5.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 1.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 5.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 4.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 7.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.9 | 373.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
11.9 | 190.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
10.0 | 79.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
8.3 | 366.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
8.2 | 114.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
8.1 | 317.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
7.8 | 70.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
7.8 | 387.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
7.1 | 192.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
6.6 | 79.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
6.5 | 64.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
6.0 | 137.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
6.0 | 41.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
5.8 | 23.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
5.4 | 85.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
5.3 | 79.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
5.3 | 79.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
5.3 | 42.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
5.2 | 78.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
5.2 | 57.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
4.9 | 58.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
4.7 | 51.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
4.5 | 53.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
4.2 | 80.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
4.2 | 33.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
4.2 | 33.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
4.1 | 41.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
4.1 | 20.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
4.1 | 28.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
3.9 | 43.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
3.5 | 35.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.2 | 73.4 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
3.1 | 18.9 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
3.1 | 18.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
3.1 | 130.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
3.0 | 407.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
2.8 | 25.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
2.8 | 14.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.7 | 8.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.6 | 62.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.6 | 264.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
2.5 | 25.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
2.5 | 7.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
2.4 | 65.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
2.4 | 28.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.2 | 24.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
2.2 | 15.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
2.1 | 88.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
2.1 | 14.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.1 | 144.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
2.0 | 15.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.0 | 43.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.9 | 34.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.9 | 30.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.8 | 7.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.8 | 79.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.8 | 41.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.7 | 22.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.7 | 32.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.7 | 38.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.6 | 52.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.6 | 200.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
1.6 | 15.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.5 | 41.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.5 | 33.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.4 | 18.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.4 | 26.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.4 | 32.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.3 | 30.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.3 | 21.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.3 | 10.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.3 | 36.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.3 | 8.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.2 | 21.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
1.2 | 26.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.2 | 12.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.2 | 11.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.2 | 24.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.1 | 11.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.1 | 18.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 6.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 19.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.0 | 22.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 66.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.9 | 11.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 38.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.9 | 1.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.8 | 75.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.8 | 9.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 41.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.8 | 22.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.8 | 14.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 59.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 8.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 38.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 31.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.7 | 56.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.7 | 9.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 7.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 14.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 5.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 7.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 5.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 9.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.6 | 4.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.5 | 5.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.5 | 9.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 7.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.4 | 6.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 20.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 7.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 12.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 9.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 6.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 5.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 23.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 6.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 6.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 6.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 5.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 5.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 7.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 2.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 7.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 4.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 6.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 4.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 12.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 3.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |